CVS Health will invest $8.7 million in the Mercy Drive neighborhood and expand its Project Health program as part of its nearly $600 million commitment to address racial inequality.
Eli Lilly's bamlanivimab has received the Food and Drug Administration’s nod for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.
Pfizer said that its vaccine candidate has shown more than 90% efficacy in preventing COVID-19 among participants who had not previously been infected with SARS-CoV-2 in the first interim efficacy analysis.